Patenting AI-generated inventions – is patent law acting the luddite?
by Dr. Nora E. Wessendorf, LL.M. (Washington)
The first 100 days of the UPC from a life sciences perspective – a very good message
by Dr. Anja Lunze, LL.M. and Dr. Nora E. Wessendorf, LL.M. (Washington)
OLG Brandenburg: Infringement of the price fixing for prescription-only medicinal products through granting cash discount for prompt payment
by Dr. Daniel Tietjen and Katharina Hölle
Federal Court of Justice (BGH): Cease and desist letter due to lack of indication of the basic price when selling food supplements in capsule form
by Dr. Daniel Tietjen
Decision of the Unified Patent Court (UPC) secured - what now?
by multiple authors
What confidentiality protection is available?
by Matthew Royle, Ph.D.
How do I enforce a UPC decision?
by Julius Zacharias
Is cross-examination possible in the UPC?
by Chris Thornham
Can I use party appointed experts in the UPC?
by Charlotte Garnitsch
How is evidence used at the UPC?
by Verena Bertram
What are the chances of an action being bifurcated and what are the safeguards?
by Patricia Cappuyns
Personalised medicines and exclusive protection
by Dr Paul England
© Taylor Wessing